$Evaluation of the additive effect of interferon α 2b with monthly intravitreal injection of bevacizumab in refractory diabetic macular edema$

Evaluation of the additive effect of interferon α 2b with monthly intravitreal injection of bevacizumab in refractory diabetic macular edema

Abstract Background To evaluate the additive effect of topical or sub-tenon injection of interferon (IFN)-α 2b in the treatment of refractory diabetic macular edema. Methods In this prospective study patients with center-involved DME who were unresponsive to 3 monthly consecutive IVB injections were...

Full description

Bibliographic Details
Main Authors:	Hooshang Faghihi, Bahman Inanloo, Arash Mirzaee, Kaveh Fadakar, Ahmad Mirshahi, Nazanin Ebrahimiadib, Fariba Ghassemi, Fatemeh Bazvand, Abdulrahman Amini, Masoud Mirghorbani, Shahin Faghihi, Elias Khalili Pour, Hamid Riazi-Esfahani
Format:	Article
Language:	English
Published:	BMC 2022-10-01
Series:	International Journal of Retina and Vitreous
Subjects:	Diabetic retinopathy Refractory diabetic macular edema Interferon-alpha Anti-vascular endothelial growth factor (Anti-VEGF)
Online Access:	https://doi.org/10.1186/s40942-022-00424-x

Similar Items

Intraocular Injection of StivantⓇ (A Biosimilar to Bevacizumab): A Case Series
by: Ahmad Mirshahi, et al.
Published: (2021-01-01)

Choroidal features in flat irregular pigment epithelial detachment associated with Chronic central serous chorioretinopathy: Avascular versus vascularized.
by: Hooshang Faghihi, et al.
Published: (2021-01-01)

Safety of Intravitreal Injection of Stivant, a Biosimilar to Bevacizumab, in Rabbit Eyes
by: Alireza Lashay, et al.
Published: (2020-08-01)

Flat irregular pigment epithelial detachment over time and outcome of different treatment regimens
by: Nazanin Ebrahimiadib, et al.
Published: (2022-06-01)

The quantitative measurements of foveal avascular zone using optical coherence tomography angiography in normal volunteers
by: Fariba Ghassemi, et al.
Published: (2017-12-01)

Effects of panretinal photocoagulation on retinal vasculature and foveal avascular zone in diabetic retinopathy using optical coherence tomography angiography: A pilot study
by: Ahmad Mirshahi, et al.
Published: (2019-09-01)

Microperimetry and OCT angiography evaluation of patients with ischemic diabetic macular edema treated with monthly intravitreal bevacizumab: a pilot study
by: Felipe Pereira, et al.
Published: (2019-09-01)

Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab
by: Shakarchi FI, et al.
Published: (2018-12-01)

Intravitreal Medications for Retinal Vein Occlusion: Systematic Review and Meta-analysis
by: Alireza Lashay, et al.
Published: (2019-07-01)

Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration
by: Mohammad Riazi-Esfahani, et al.
Published: (2008-12-01)

Henle fiber layer hemorrhage associated with combined central retinal vein occlusion and cilioretinal artery occlusion: a case report
by: Hamid Riazi-Esfahani, et al.
Published: (2023-08-01)

Efficacy of intravitreal bevacizumab for the treatment of Zone I Type 1 retinopathy of prematurity
by: Reza Karkhaneh, et al.
Published: (2018-01-01)

Pre-operative intravitreal bevacizumab for tractional retinal detachment secondary to proliferative diabetic retinopathy: the Alvaro Rodriguez lecture 2023
by: J. Fernando Arevalo, et al.
Published: (2023-04-01)

Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections
by: Levin AM, et al.
Published: (2017-01-01)

Electroretinogram Changes Following Sequential Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
by: Khojasteh H, et al.
Published: (2020-03-01)

The Association of Intravitreal Anti-VEGF Injections With Kidney Function in Diabetic Retinopathy
by: Casey C. Bunge, MD, et al.
Published: (2023-12-01)

Hemicentral retinal vein occlusion in a patient with a history of coronavirus disease 2019 infection: a case report and review of the literature
by: Hamid Riazi-Esfahani, et al.
Published: (2024-02-01)

Automatic Choroid Vascularity Index Calculation in Optical Coherence Tomography Images with Low-Contrast Sclerochoroidal Junction Using Deep Learning
by: Roya Arian, et al.
Published: (2023-02-01)

Effect of intravitreal aflibercept on recalcitrant diabetic macular edema
by: Kendra A. Klein, et al.
Published: (2017-04-01)

Intravitreal Bevacizumab in Vitreous Hemorrhage and Diabetes Mellitus
by: Beuy Joob, et al.
Published: (2017-03-01)

The effect of panretinal photocoagulation (PRP) versus intravitreal bevacizumab (IVB) plus prp on peripapillary retinal nerve fiber layer (RNFL) thickness analyzed by optical coherence tomography in patients with proliferative diabetic retinopathy
by: Ramak Roohipour, et al.
Published: (2019-01-01)

Outcomes of three intravitreal injections of bevacizumab given monthly for diabetic macular oedema is a viable treatment for an economically disadvantaged population
by: Aazambir S. Brar, et al.
Published: (2021-04-01)

COMPARATIVE EVALUATION OF INTRAVITREAL DICLOFENAC PLUS BEVACIZUMAB VERSUS BEVACIZUMAB ALONE IN THE TREATMENT OF NAÏVE DIABETIC MACULAR EDEMA: A RANDOMIZED CONTROLLED TRIAL
by: Adnan Ahmad, et al.
Published: (2022-12-01)

Short-term outcomes in patients with center-involving diabetic macular edema after a single dose of intravitreal bevacizumab
by: Christopher A. Turski, et al.
Published: (2022-11-01)

Short-term intraocular pressure changes after intravitreal bevacizumab injection
by: Ali Dehghani, et al.
Published: (2014-08-01)

Short-term intraocular pressure changes after intravitreal bevacizumab injection
by: Ali Dehghani, et al.
Published: (2014-06-01)

One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
by: Tran THC, et al.
Published: (2021-05-01)

Intravitreal Bevacizumab Alone Versus Combined Bevacizumab and Macular Grid Laser Photocoagulation in Diffuse Diabetic Macular Oedema
by: Fawaz Al Sarireh, et al.
Published: (2020-11-01)

Mortality in patients treated with intravitreal bevacizumab for age-related macular degeneration
by: Joel Hanhart, et al.
Published: (2017-10-01)

Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
by: Ribeiro de Carvalho G, et al.
Published: (2020-09-01)

Intravitreal triamcinolone versus intravitreal bevacizumab for diabetic macular edema:a meta-analysis
by: Xiao-Ling Zhang, et al.
Published: (2013-08-01)

The quantitative measurements of choroidal thickness and volume in diabetic retinopathy using optical coherence tomography and optical coherence tomography angiography; correlation with vision and foveal avascular zone
by: Fariba Ghassemi, et al.
Published: (2022-01-01)

Evaluation Of Choroidal Thickness Before and After Intravitreal Injection Of Anti Vascular endothelial growth factors for Treatment Of Diabetic Macular Edema using Optical Coherence Tomography
by: Noha Mahmoud Ahmed Mohamed *, et al.
Published: (2023-07-01)

The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects
by: Cengiz Alagöz, et al.
Published: (2016-10-01)

Effect of intravitreal injection of bevacizumab-chitosan nanoparticles on retina of diabetic rats
by: Yan Lu, et al.
Published: (2014-02-01)

Macular Edema Formation and Deterioration of Retinal Function after Intravitreal Bevacizumab Injection for Proliferative Diabetic Retinopathy
by: Hisanori Imai, et al.
Published: (2011-09-01)

ANTI-OXIDANT AND ANTI-DIABETIC ACTIVITIES OF ETHANOLIC EXTRACT OF Primula denticulata FLOWERS
by: Hemlata Bhatt, et al.
Published: (2016-04-01)

Intravitreal bevacizumab versus bevacizumab and 1 mg triamcinolone acetonide in eyes with bilateral diabetic macular edema
by: Sever Ozkan, et al.
Published: (2019-01-01)

Quantitative assessment of vascular density in diabetic retinopathy subtypes with optical coherence tomography angiography
by: Fariba Ghassemi, et al.
Published: (2021-02-01)

Prefilled syringes for intravitreal drug delivery
by: Sassalos TM, et al.
Published: (2019-04-01)